by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Bio Technology : July 2009
AusBioTALK ABBA-winning scientist aims for more discoveries and improved speed to market TGR BioSciences’ Dr Michael Crouch has been named winner of the 2009 Advancing BioBusiness Award Winner. Dr Crouch is the Chief Scientific Officer for the Adelaidebased company that creates assay, or test, technologies for the global drug discovery market. Dr Crouch was selected from a highly competitive field of candidates for the prestigious 2009 Advancing BioBusiness Awards, which will see him attend the world’s largest biotechnology meeting, the Biotechnology Industry Organisation (BIO) convention. Dr Michael Crouch says slashing the time it takes for new medicines to reach consumers and improving scientific discovery in Australia were top of the agenda when he met with key industry figures in the US in May. His prize included support to attend BIO in Atlanta and a targeted meeting schedule while there. The award is an innovative scheme by leading pharmaceutical company Merck Sharp & Dohme and Advance, a dynamic, diverse global community of Australian professionals overseas committed to advancing Australia and Australians. Developing new medicines requires pharmaceutical companies to test millions of drug compounds to see if they are potentially effective – a process which in the past has been slow and laborious said Dr Crouch. Through his award win, Dr Crouch says he is hoping to advance his contacts so he can better understand the needs of the industry including how pharmaceutical companies select drug targets, what they would like to see in a new assay approach and how they make decisions on which technologies to use. 30 Australasian BioTechnology Volume 19 • Number 2 • July 2009